skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: assunto: Medical Sciences remover assunto: Treatment Outcome remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Secukinumab in Plaque Psoriasis — Results of Two Phase 3 Trials

Langley, Richard G ; Elewski, Boni E ; Lebwohl, Mark ; Reich, Kristian ; Griffiths, Christopher E.M ; Papp, Kim ; Puig, Lluís ; Nakagawa, Hidemi ; Spelman, Lynda ; Sigurgeirsson, Bárður ; Rivas, Enrique ; Tsai, Tsen-Fang ; Wasel, Norman ; Tyring, Stephen ; Salko, Thomas ; Hampele, Isabelle ; Notter, Marianne ; Karpov, Alexander ; Helou, Silvia ; Papavassilis, Charis

The New England journal of medicine, 2014-07, Vol.371 (4), p.326-338 [Periódico revisado por pares]

Waltham, MA: Massachusetts Medical Society

Texto completo disponível

Citações Citado por
2
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusions
Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusions
Material Type:
Artigo 		Adicionar ao Meu Espaço

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: Case-based presentations and evidence-based conclusions

MENTER, Alan ; KORMAN, Neil J ; LIM, Henry W ; VAN VOORHEES, Abby S ; BEUTNER, Karl R ; RYAN, Caitriona ; BHUSHAN, Reva ; ELMETS, Craig A ; FELDMAN, Steven R ; GELFAND, Joel M ; GORDON, Kenneth B ; GOTTLIEB, Alice ; KOO, John Y. M ; LEBWOHL, Mark ; LEONARDI, Craig L

Journal of the American Academy of Dermatology, 2011-07, Vol.65 (1), p.137-174 [Periódico revisado por pares]

New York, NY: Elsevier

Texto completo disponível

Citações Citado por
3
Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety of systemic treatments for moderate-to-severe psoriasis: meta-analysis of randomized controlled trials

Schmitt, J. ; Rosumeck, S. ; Thomaschewski, G. ; Sporbeck, B. ; Haufe, E. ; Nast, A.

British journal of dermatology (1951), 2014-02, Vol.170 (2), p.274-303 [Periódico revisado por pares]

Oxford: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
4
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor α inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial

Smolen, Josef S, Prof ; Kay, Jonathan, MD ; Doyle, Mittie K, MD ; Landewé, Robert, MD ; Matteson, Eric L, Prof ; Wollenhaupt, Jürgen, Prof ; Gaylis, Norman, MD ; Murphy, Frederick T, MD ; Neal, Jeffrey S, MD ; Zhou, Yiying, PhD ; Visvanathan, Sudha, PhD ; Hsia, Elizabeth C, MD ; Rahman, Mahboob U, MD

The Lancet (British edition), 2009-07, Vol.374 (9685), p.210-221 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
5
Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study
Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study

Esposito, M. ; Gisondi, P. ; Cassano, N. ; Ferrucci, G. ; Del Giglio, M. ; Loconsole, F. ; Giunta, A. ; Vena, G.A. ; Chimenti, S. ; Girolomoni, G.

British journal of dermatology (1951), 2013-09, Vol.169 (3), p.666-672 [Periódico revisado por pares]

Oxford: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network
Material Type:
Artigo 		Adicionar ao Meu Espaço

'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network

van den Reek, J.M.P.A. ; Zweegers, J. ; Kievit, W. ; Otero, M.E. ; van Lümig, P.P.M. ; Driessen, R.J.B. ; Ossenkoppele, P.M. ; Njoo, M.D. ; Mommers, J.M. ; Koetsier, M.I.A. ; Arnold, W.P. ; Sybrandy-Fleuren, B.A.M. ; Kuijpers, A.L.A. ; Andriessen, M.P.M. ; van de Kerkhof, P.C.M. ; Seyger, M.M.B. ; de Jong, E.M.G.J.

British journal of dermatology (1951), 2014-11, Vol.171 (5), p.1189-1196 [Periódico revisado por pares]

Oxford: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
7
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial
Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Effects of etanercept versus sulfasalazine in early axial spondyloarthritis on active inflammatory lesions as detected by whole-body MRI (ESTHER): a 48-week randomised controlled trial

Song, I-H ; Hermann, KG ; Haibel, H ; Althoff, CE ; Listing, J ; Burmester, GR ; Krause, A ; Bohl-Bühler, M ; Freundlich, B ; Rudwaleit, M ; Sieper, J

Annals of the rheumatic diseases, 2011-04, Vol.70 (4), p.590-596 [Periódico revisado por pares]

London: BMJ Publishing Group Ltd and European League Against Rheumatism

Texto completo disponível

Citações Citado por
8
Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients
Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients
Material Type:
Artigo 		Adicionar ao Meu Espaço

Anti-TNF Agents for Behçet's Disease: Analysis of Published Data on 369 Patients

Arida, Aikaterini, MD ; Fragiadaki, Kalliopi, MD ; Giavri, Eirini, MD ; Sfikakis, Petros P., MD

Seminars in arthritis and rheumatism, 2011-08, Vol.41 (1), p.61-70 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
9
Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and safety results from a phase III, randomized controlled trial comparing the safety and efficacy of briakinumab with etanercept and placebo in patients with moderate to severe chronic plaque psoriasis

Strober, B.E. ; Crowley, J.J. ; Yamauchi, P.S. ; Olds, M. ; Williams, D.A.

British journal of dermatology (1951), 2011-09, Vol.165 (3), p.661-668 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
10
TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis
TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis
Material Type:
Artigo 		Adicionar ao Meu Espaço

TNFAIP3 Gene Polymorphisms Are Associated with Response to TNF Blockade in Psoriasis

Tejasvi, Trilokraj ; Stuart, Philip E. ; Chandran, Vinod ; Voorhees, John J. ; Gladman, Dafna D. ; Rahman, Proton ; Elder, James T. ; Nair, Rajan P.

Journal of investigative dermatology, 2012-03, Vol.132 (3), p.593-600 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Recursos Online (525)
  2. Revistas revisadas por pares (467)

Data de Publicação 

De até
Refinar
  1. Antes de2001  (8)
  2. 2001Até2003  (54)
  3. 2004Até2006  (116)
  4. 2007Até2010  (205)
  5. Após 2010  (148)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.